What happens in vagus
- 1Department of Neurology, University of California, Los Angeles and California Rehabilitation Institute
Abstract
The parasympathetic nervous system is phylogenetically ancient. In humans, the vagus nerve is the brain’s only pathway for bidirectional parasympathetic signaling with the thorax, abdomen, and upper pelvis. Unsurprisingly, the vagus nerve has played a significant role in scientific discovery and therapeutic applications, attracting the attention of Galen, Darwin, and Pavlov, among others. For example, Otto Loewi used the vagus nerve to gather data that confirmed Santiago Ramón y Cajal’s Neuron Doctrine. This intensive focus has led to a number of clinical advances related to vagus nerve function, including theories about mind–body connections. Interestingly, reducing vagus nerve activity has been a successful strategy for some clinical conditions, such as peptic ulcer disease and obesity. In other conditions, increasing vagus nerve activity has been successful at improving patient outcomes, for example, in refractory seizures, drug-resistant depression, and stroke recovery; in each of these three conditions, the FDA has approved vagus nerve stimulation as a therapeutic intervention. Potential future developments in the therapeutic modulation of vagus nerve activity are discussed, including its role in perinatal brain development; manipulation of the vagus nerve as a portal for CNS access, as suggested in Parkinson’s disease; and closed-loop systems that modulate vagus nerve activity in response to measurement of various forms of signaling, an approach that would be aided by the capacity to directly measure activity in individual vagus nerves.
Related
- What Happens After Assessment?
- What happens when sugar-sweetened beverage labelling and tax policies are extended to non-sugar sweetened beverages? A national study of Australians’ responses
- What Happens to the General Practitioner When the Pharmacist Tests for Strep Throat? A Systematic Review of Community Pharmacy Sore Throat Services and Their Consequences for General Practice.
- “What happens at the doctor’s?”: a qualitative study exploring social representations and experiential knowledge of medical consultation in 5–6 year-olds
- Distinguishing clinical efficacy from vagal target engagement in perioperative transcutaneous auricular vagus nerve stimulation.
BibTeX
@article{cramer2026what,
title = {{What happens in vagus}},
author = {Steven C. Cramer},
journal = {Frontiers in Neurology},
year = {2026},
month = oct,
doi = {10.3389/fneur.2026.1901477},
url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1901477/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - What happens in vagus
AU - Steven C. Cramer
PY - 2026
DA - 2026/10/01
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1901477
UR - https://www.frontiersin.org/articles/10.3389/fneur.2026.1901477/full
AB - The parasympathetic nervous system is phylogenetically ancient. In humans, the vagus nerve is the brain’s only pathway for bidirectional parasympathetic signaling with the thorax, abdomen, and upper pelvis. Unsurprisingly, the vagus nerve has played a significant role in scientific discovery and therapeutic applications, attracting the attention of Galen, Darwin, and Pavlov, among others. For example, Otto Loewi used the vagus nerve to gather data that confirmed Santiago Ramón y Cajal’s Neuron Doctrine. This intensive focus has led to a number of clinical advances related to vagus nerve function, including theories about mind–body connections. Interestingly, reducing vagus nerve activity has been a successful strategy for some clinical conditions, such as peptic ulcer disease and obesity. In other conditions, increasing vagus nerve activity has been successful at improving patient outcomes, for example, in refractory seizures, drug-resistant depression, and stroke recovery; in each of these three conditions, the FDA has approved vagus nerve stimulation as a therapeutic intervention. Potential future developments in the therapeutic modulation of vagus nerve activity are discussed, including its role in perinatal brain development; manipulation of the vagus nerve as a portal for CNS access, as suggested in Parkinson’s disease; and closed-loop systems that modulate vagus nerve activity in response to measurement of various forms of signaling, an approach that would be aided by the capacity to directly measure activity in individual vagus nerves.
SN - 1664-2295
ER -